August 23, 2019

Affordable prescription drugs are essential to ensuring that Americans can live long and healthy lives. Unfortunately, rising drug costs are ensuring that many people cannot afford their medications. And health insurance companies, pharmacy benefit managers (PBMs), and...

August 12, 2019

Large mergers are usually harmful for consumers and competition. Instead of lower prices and increased innovation, consumers get higher prices, less access to goods and services, and reduced innovation and research. Mergers in the pharmaceutical industry are no excepti...

August 8, 2019

Anticompetitive behavior by brand name companies and generic drug companies is one reason why prescription drug prices are so high. These abuses have become increasingly prevalent over the past few years; fortunately members of Congress recognize this problem and are w...

August 5, 2019

Over the past several decades pharmacy benefit managers (PBMs) have acquired substantial power and influence in our health care system, to the point that they often make decisions that affect prescription drug costs and patient access to these drugs. One unfortunate tr...

August 1, 2019

A great deal of prescription drug research and development is funded by the National Institutes of Health (NIH) and other federal programs, and this support has lead to amazing new medicines. But too often, patients do not benefit from these drugs because drug companie...

Please reload

Featured Posts

United States-Mexico-Canada Agreement (USMCA)

October 5, 2018

1/4
Please reload

Recent Posts
Please reload

Archive